# Hefei Leaf Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hefei-leaf-biotech-co

- Industry: Biotechnology
- Headquarters: Hefei, China
- Website: www.leafresource.com
- Total disclosed funding: $28M
- Latest round: Series B (Aug 6, 2025)
- Investors on record: 10

## About

Established in 2014 and based in Hefei, China, Hefei Leaf Biotech Co., Ltd. operates as a biobased materials and intermediates developer that provides furan dicarboxylic acid (FDCA) and pentahydroxymethyl furfural (HMF). The company cooperates with CIAC and University of Science and Technology of China, the core research team has more than 40 employees and over 90% of employees have a bachelor's degree. It has R&D center in Hefei which covers an area of 1600 square meters, and production based located in Xuancheng and Bengbu. In 2016, the company awarded as a high-tech enterprise. In August 2025, it closed a round of venture funding. The company's products include new bio-based materials, such as bio-based furan new materials, furan-based polyester series materials and furan-based polyaryl ether amide special fiber. It also provides biomedica business, including CDMO services and industrialization projects. The company generates revenue through the sales of its pharmaceuticals related drugs and services.

## Funding rounds

- Series B, Aug 6, 2025 — Anhui Guoyao Venture Capital Management, Jiyuan Capital, Guoyuan Equity Investment, Xinfengming
- Series B, Jun 25, 2023, $28M — Huagai Capital, Guanzi Private Equity Management (Hangzhou), Sino Blue Venture Capital, Zehui Capital
- Series A, May 9, 2017 — Hefei High-tech Venture Capital, Anhui Provincial Emerging Industry Investment
- Angel, Oct 23, 2015 — Anhui Guoyao Venture Capital Management

## Investors

- Anhui Guoyao Venture Capital Management (https://capitalatlas.ai/funds/anhui-guoyao-venture-capital-management) — Angel, Series B
- Hefei High-tech Venture Capital (https://capitalatlas.ai/funds/hefei-high-tech-venture-capital) — Series A
- Anhui Provincial Emerging Industry Investment — Series A
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series B
- Guanzi Private Equity Management (Hangzhou) — Series B
- Sino Blue Venture Capital — Series B
- Zehui Capital — Series B
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series B
- Guoyuan Equity Investment (https://capitalatlas.ai/funds/guoyuan-equity-investment) — Series B
- Xinfengming — Series B